 |
 |
|
Eva
M. Balash, MD, of Boston Family Dermatology, is a board certified
dermatologist at Faulkner Hospital and also serves as Clinical Assistant
Professor of Dermatology at Boston University School of Medicine
A: There are several steps that you can take to protect your
skin from overexposure to the sun. First, it is important to note
that any level of tanning is your skin's way of telling you that
it has been damaged. It is also important to remember that overexposure
to the sun is the primary cause in developing skin cancer. The sun
is strongest during the hours of 10:00 a.m. to 4:00 p.m. While exposure
to the sun during these hours should be avoided, there are several
precautions you can take.
If you know that you will be in the sun during these hours, you
should:
- Apply sunscreen that has a UVA/UVB blocker and Sun Protection
Factor (SPF) of at least 15 (preferably 30) on all exposed areas
of the skin. This should be done 30 minutes before you expect
to be in the sun.
- Reapply sunscreen every two hours and after you have finished
swimming or if you have experienced excessive perspiration while
out in the sun.
- Whenever possible, wear protective clothing such as a hat when
you are being exposed to the sun.
|
 |
A: Even though we are more covered with
clothing during winter months, parts of our skin are still exposed
to the sun. The sun rises every day and UV light is present, mostly
in the form of UVA. As a rule, while outside, any part of the skin
not covered by clothing should be covered by sun block. It is also
important to remember that sun reflects off snow on the ground, increasing
the risks of sun damage to skin. |
 |
 |
A: In theory, everyone is at risk. However, fair-skinned people,
especially those with red or blond hair, who tend to burn rather
than tan, are most likely to develop skin cancer. This is because
their skin cells have less melanin, which is the pigment that helps
prevent sunburn. In other words, the darker the skin, the more melanin
there is present.
Another group that is at risk includes those individuals who suffered
severe sunburns as children. Parents should note that they should
protect their children by practicing sun safety, and they should
also teach children good sun block habits for the future.
Lastly, those who have a family history of skin cancer are at greater
risk themselves. Having a family history usually means a sibling,
parent or another close relative had skin cancer such as melanoma.
If you have any of these risk factors, please speak to your primary
care physician or contact a dermatologist.
|
 |
 |
A: According to the American Cancer Society, any unusual, non-healing
sore, lump or blemish may be a sign of skin cancer. A lesion or
growth that is crusty, scaly, oozing or bleeding is also another
possible symptom of skin cancer. While most skin problems do not
turn out to be cancer, the only way to be sure is to be examined
by a specialist.
Whether you are at risk or not, you should learn what your skin
normally looks like. If you have this knowledge, you will know when
something seems out of the ordinary. The best time to do this exercise
is while standing in front of a full-length mirror or after taking
a bath or a shower. A hand-held mirror can be used for those areas
that are hard to see. You should also examine the palms of your
hands, soles of your feet, spaces between your fingers and toes
as well as your scalp (a hairdresser or family member can help with
this).
Basal cell cancers are the most common skin cancer and often first
appear as small, round or oval patches that are shiny and firm and
are pale, but sometimes pink or red. Roughly 75 percent of all skin
cancers are this type. Squamous cell cancers account for roughly
20 percent of all cancers and are usually small, round, slightly
raised and are red and crusty. Often there is a sore in the center
that does not heal, especially in the later stages.
Melanomas, which can appear on any area of the skin, often resemble
moles. The easy-to-remember ABCD rule will help you in distinguishing
a normal mole or other marking from one that could be a melanoma.
If any of the following descriptions apply to any of your moles,
please contact your physician immediately:
ASYMMETRY--One half does not match the other.
BORDER IRREGULARITY--The edges of the mole are ragged, notched or
blurred.
COLOR--The color is not the same over the entire mole, but may be
differing shades of tan, brown or black, sometimes with patches
of red, white or blue.
DIAMETER--The mole is wider than 6 millimeters, (the size of a pencil
eraser) or is growing larger.

|
 |
|
Robert
Eyre, MD, of the Faulkner Hospital Division of Urology, answers
your questions on the topic of prostate cancer, a disease that affects
one out of eleven men and takes 30,200 lives, annually.
A: Prostate specific antigen (PSA) is a protein made by the
cells within the prostate, a walnut sized gland at the base of the
bladder. All prostate cells, both benign and malignant, create PSA.
Therefore, as the prostate gland enlarges with the normal male aging
process (usually beginning in the mid-forties), it is normal for
the PSA to slowly increase. We measure it by taking blood from a
vein in the arm. Statistically, men who have a PSA value higher
than the "normal" range are at higher risk for having
prostate cancer. Since the test is very non-specific, it might detect
elevated levels of PSA that are caused by other factors, among which
are prostate gland infection, recent catheterization, or benign
enlargement causing urinary difficulties. It is important for all
men over age 50 to be tested every 12 months because the change
in PSA value over the course of one year is a key determinant of
cancer risk. Coupled with a digital rectal examination (DRE) of
the prostate, the PSA test is very useful in revealing which men
need further evaluation with a prostate ultrasound and biopsy.
|
 |
 |
A. Absolutely. The risk that an American
male will be diagnosed with prostate cancer during his lifetime is
approximately one in eleven. If there is a family history of prostate
cancer in a "first order" male relative such as a brother,
father or uncle, the risk increases to one in three men. If two first-order
male relatives have had prostate cancer, the risk increases to about
one in two. Studies have shown that men with a family history of prostate
cancer tend to develop cancer at an earlier age and have a higher
volume of cancer in their prostate gland. Therefore, it is critical
for men with a family history of prostate cancer to start their annual
surveillance with PSA testing and a DRE at age 40 instead of 50. |
 |
 |
A: Several years ago, concern was raised about a possible link
between a vasectomy and prostate cancer. However, more recent studies
have shown no association between the two. The most extensive of
these studies was published in the October 1999 issue of Cancer
Epidemiology, Biomarkers & Prevention.
To learn more about Prostate Cancer, please contact your primary
care physician or Dr. Eyre at (617) 732-9806.
|
 |
|
Norman
Sadowsky, MD, Chief of Radiology and Medical Director of the Faulkner-Sagoff
Centre and colleague Elsie Levin, MD, Associate Director of the
Faulkner-Sagoff Centre answer your questions about mammography and
breast cancer prevention. Breast cancer affects one in eight women
and takes over 45,000 lives, annually.
A: Dr. Levin: You should begin scheduling annual mammograms
starting at age 40. If, however, you have a first degree relative
(mother or sister) who has been diagnosed with pre-menopausal breast
cancer, you should start screenings 10 years prior to the age of
that relative's diagnosis. For instance, if your mother was diagnosed
with breast cancer at age 45, you should begin screenings at age
35. It is important to remember that mammography is only one part
of breast cancer screening, which also includes regular physician
check-ups and breast self-examinations.
|
 |
 |
A: Dr. Sadowsky: 10% of all breast cancers
are related to one of two abnormal genes known as BRCA1 and BRCA2.
There is a 65%-85% chance that a person with one of these genes will
get breast cancer. We follow these patients closely with mammograms,
ultrasound and MRI. Patients with these genes should speak with their
primary care physician and a genetic counselor to discuss an appropriate
course of action, which could include breast or ovary removal. There
are many other risks to consider before a decision to operate is made. |
 |
 |
A: Dr. Sadowsky: Aside from
having one of the two abnormal genes, there are three major risk factors
that we must take into account. A woman is at greater risk for breast
cancer if she has a first degree relative with breast cancer, if she
has had a biopsy that shows atypical changes in the breast, or if
she, herself has previously been diagnosed with breast cancer. It
is imperative, however, to keep in mind that two thirds of all breast
cancers occur in women who have no significant risk factors. |
 |
 |
A: Dr. Levin: MRI can be used
for patients with newly diagnosed breast cancer prior to surgery to
evaluate the extent of the disease and to help plan the appropriate
surgery. It is also used prior to surgery to evaluate tumor response
in patients being treated with chemotherapy. MRI functions as a problem
solving tool when a patient has a lump that can not be seen with mammography
or ultrasound, or when mammography leads to ambiguous findings. The
usefulness of MRI as a screening tool is being evaluated in clinical
trials. It may be found to be helpful for patients who are at high
risk for breast cancer, or who have dense breast tissue. Most importantly,
MRI is to be used in addition to, not as a replacement for, mammography. |
 |
 |
To learn more about mammography,
or to make an appointment, call the Faulkner-Sagoff Breast Imaging
and Diagnostic Centre at (617) 983-7272.

For information on free mammograms for uninsured women over 40, please
call the Faulkner Hospital Community Health and Benefits Department
at (617) 983-7451.
|
 |
|
Benjamin
Smith, MD, director of the Gastrointestinal Endoscopy Unit and colleague,
gastroenterologist Ewa Preneta, MD, answer your questions about
colon cancer screening.
A: Dr. Preneta: Anytime and particularly if you have symptoms
or are at high risk. Screening should begin at age 50 for men and
for women with no risk factors. For those with a family history
of colorectal cancer, screening should begin at age 40 or younger
depending on the situation.
|
 |
 |
A: Dr. Smith: There are currently four
screening procedures available: colonoscopy, flexible sigmoidoscopy,
fecal occult blood test (stool card test) and barium enema. Colonoscopy
is the most reliable screening tool we have. It shows the entire colon
and allows us the ability to remove growths (polyps) if needed during
the exam. A flexible sigmoidoscopy, on the other hand, allows us to
see one-third of the colon. Recent studies suggest that flexible sigmoidoscopies
diagnose approximately two-thirds of all colon cancers. We think we
can do better with screening colonoscopy. |
 |
 |
A: Dr. Smith: Yes. There is a new colorectal
cancer screening benefit for Medicare beneficiaries that became effective
July 1, 2001. If you have no risk factors other than age, we would
suggest a colonoscopy every ten years. An annual stool card test and
a flexible sigmoidoscopy are an alternative screening strategy.

To find out more about colon cancer screening, please ask your primary
care physician or call Gastroenterology Associates at Faulkner Hospital
at
(617) 522-9996. |
 |
| Please ask your primary care physician
or call Gastroenterology Associates at Faulkner Hospital at (617)
522-9996 to find out more about colon cancer screening |
|